| <img alt="" height="1" width="1" />LXRX: Management Comments on Positive Phase 2 Results for LX1031 in IBSTrading Markets (press release)The study included 155 patients with either diarrhea-predominant IBS or mixed IBS. Two dose levels were evaluated: a 250 mg dose and a 1000 mg dose, ...<nobr>and more »</nobr> |
Google- LXRX: Management Comments on Positive Phase 2 Results for LX1031 in IBS - Trading Markets (press release)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!